Gary Charles Robb - 22 Nov 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Issuer symbol
CORT
Transactions as of
22 Nov 2022
Net transactions value
-$130,150
Form type
4
Filing time
23 Nov 2022, 17:30:12 UTC
Previous filing
21 Nov 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Sale $125,308 -4,814 -18% $26.03 21,329 22 Nov 2022 Direct F1
transaction CORT Common Stock Sale $4,842 -186 -0.87% $26.03 21,143 23 Nov 2022 Direct F1
holding CORT Common Stock 5,814 22 Nov 2022 Custodial Account for Child F2
holding CORT Common Stock 5,814 22 Nov 2022 Custodial Account for Child F2
holding CORT Common Stock 5,814 22 Nov 2022 Custodial Account for Child F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.